IPC-klasse
Fullmektig i Norge:
Org.nummer: 910476068
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2009.03.24, US 162848 P
ARGYRIOU ANDREAS A ET AL: "Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature" BLOOD, vol. 112, no. 5, September 2008 (2008-09), pages 1593-1599, XP002594460 ISSN: 0006-4971 (B1)
BADROS ASHRAF ET AL: "Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature" CANCER, vol. 110, no. 5, September 2007 (2007-09), pages 1042-1049, XP002594459 ISSN: 0008-543X (B1)
CORTHALS SOPHIE L ET AL: "Genetic Associations with Bortezomib Mediated Neuropathy in Multiple Myeloma." BLOOD, vol. 114, no. 22, November 2009 (2009-11), page 713, XP002594463 & 51ST ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; NEW ORLEANS, LA, USA; DECEMBER 05 -08, 2009 (B1)
WO-A1-2008/028687 (B1)
KUIPER ROWAN ET AL: "Developing a SNP Classifier for Predicting Peripheral Neuropathy by Bortezomib in Multiple Myeloma Patients." BLOOD, vol. 114, no. 22, ABS.1800, November 2009 (2009-11), XP002594464 & 51ST ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; NEW ORLEANS, LA, USA; DECEMBER 05 -08, 2009 (B1)
RICCI DEBORAH S ET AL: "Pharmacogenomic (PGx) Analysis of Bortezomib-Associated Peripheral Neuropathy in the Phase 3 VISTA Trial of Bortezomib Plus Melphalan-Prednisone Versus Melphalan-Prednisone in Multiple Myeloma" BLOOD; 51ST ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; NEW ORLEANS, LA, USA; DECEMBER 05 -08, 2009, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 114, no. 22, 20 November 2009 (2009-11-20), page 1491, XP008124894 ISSN: 0006-4971 (B1)
SILVERMAN LEE ET AL: "Proteasome Inhibitor Associated Neuropathy Is Mechanism Based", BLOOD, vol. 112, no. 11, November 2008 (2008-11), page 915, & 50TH ANNUAL MEETING OF THE AMERICAN- SOCIETY-OF-HEMATOLOGY; SAN FRANCISCO, CA, USA; DECEMBER 06 -09, 2008 ISSN: 0006-4971 (B1)
EL-CHEIKH JEAN ET AL: "Features and risk factors of peripheral neuropathy during treatment with bortezomib for advanced multiple myeloma." CLINICAL LYMPHOMA & MYELOMA JUN 2008 LNKD- PUBMED:18650177, vol. 8, no. 3, June 2008 (2008-06), pages 146-152, XP002594461 ISSN: 1557-9190 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
Patent opphørt | Ikke betalt årsavgift |
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Utgående
EP Opphørt for ikke betalt årsavgift (3206)
|
Utgående
EP Påminnelse om ikke betalt årsavgift (3331) (PTEP2411535)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Batch Varsel om betaling av første årsavgift (3319)
|
Utgående
EP Registreringsbrev (3210)
|
Innkommende, AR116023454
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 9. avg. år (EP) | 2018.03.09 | 2850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2017.03.09 | 2550 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 7. avg. år (EP) | 2016.03.09 | 2200 | Computer Patent Annuities Ltd | Betalt og godkjent |
31513048 expand_more expand_less | 2015.10.07 | 5500 | Oslo Patentkontor AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|